The NUVANT Mobile Cardiac Telemetry System was designed as a patient-friendly solution for comprehensive detection and analysis of cardiac arrhythmias such as atrial fibrillation. NUVANT MCT provides up to thirty days of continuous surveillance of symptomatic and asymptomatic cardiac abnormalities to help physicians diagnose and treat cardiac arrhythmias*. Patients are continually monitored via PiiX®, an unobtrusive, water-resistant, wearable device designed for patient compliance and comfort. Automatic triggers capture ECGs for asymptomatic arrhythmias, while symptomatic patients can activate the PiiX manually to record an ECG. When either an arrhythmia is detected or when a patient manually drives ECG collection, the PiiX device automatically transmits the information via a wireless data transmitter device called zLink® to the Corventis Monitoring Center.